Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Tofacitinib may help treat severe hair loss, but more research is needed.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Methamphetamine affects gene expression in rat whisker follicles, with key genes linked to addiction.

Improved CRBN ligands make protein degraders more effective and drug-like.

Poly-D,L-lactic acid boosts hair growth in aged skin by activating hair follicle stem cells.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Alopecia areata treatment varies, with no optimal method established yet.

Trichohyalin may trigger the immune response causing alopecia areata.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

The model and estimator can predict drug exposure in kidney transplant patients well.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.